Roni Mamluk
2020
In 2020, Roni Mamluk earned a total compensation of $1.7M as President and Chief Executive Officer at Ayala Pharmaceuticals, a 150% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $146,000 |
|---|---|
| Option Awards | $397,930 |
| Salary | $361,712 |
| Stock Awards | $709,485 |
| Other | $127,889 |
| Total | $1,743,016 |
Mamluk received $709.5K in stock awards, accounting for 41% of the total pay in 2020.
Mamluk also received $146K in non-equity incentive plan, $397.9K in option awards, $361.7K in salary and $127.9K in other compensation.
Rankings
In 2020, Roni Mamluk's compensation ranked 6,158th out of 13,090 executives tracked by ExecPay. In other words, Mamluk earned more than 53.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,158 out of 13,090 | 53rd |
Division Manufacturing | 2,544 out of 5,621 | 55th |
Major group Chemicals And Allied Products | 1,023 out of 2,254 | 55th |
Industry group Drugs | 882 out of 1,954 | 55th |
Industry Biological Products, Except Diagnostic Substances | 214 out of 411 | 48th |
Source: SEC filing on April 27, 2021.
Mamluk's colleagues
We found two more compensation records of executives who worked with Roni Mamluk at Ayala Pharmaceuticals in 2020.